AI Verdict
RIME has stronger fundamentals based on our AI analysis.
RKDA vs RIME Fundamental Comparison
| Metric | RKDA | RIME |
|---|---|---|
| Revenue | $4.9M | $4.4M |
| Net Income | $-2.3M | $-15.9M |
| Net Margin | -48.1% | -361.4% |
| ROE | -56.5% | N/A |
| ROA | -35.7% | -124.7% |
| Current Ratio | 3.09x | 0.55x |
| Debt/Equity | 0.00x | N/A |
| EPS | $-1.71 | $-6.41 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RKDA vs RIME: Frequently Asked Questions
Is RKDA or RIME a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RIME has stronger fundamentals. RKDA is rated STRONG SELL (95% confidence) while RIME is rated STRONG SELL (98% confidence). This is not investment advice.
How does RKDA compare to RIME fundamentally?
Arcadia Biosciences, Inc. has ROE of -56.5% vs Algorhythm Holdings, Inc.'s N/A. Net margins are -48.1% vs -361.4% respectively.
Which stock pays higher dividends, RKDA or RIME?
RKDA has a dividend yield of N/A or no dividend while RIME has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RKDA or RIME for long term?
For long-term investing, consider that RKDA has STRONG SELL rating with 95% confidence, while RIME has STRONG SELL rating with 98% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RKDA vs RIME?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RKDA vs RIME, the AI consensus favors RIME based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.